Al-Niaimi Firas, Lyon C
Department of Dermatology, Salford Royal Hospital Trust, Manchester, UK.
J Drugs Dermatol. 2011 Jul;10(7):799-801.
Tamoxifen, a triphenylethylethylene, is an adjuvant therapy used for the treatment of oestrogen-receptor positive breast carcinoma due to its oestrogen receptor antagonist effect.1 We report here a case of rapid onset of hirsutism following administration of tamoxifen.